Skip to main content
. 2021 Jul 22;59:270–278. doi: 10.1016/j.breast.2021.07.016

Table 2.

CDR and recall rate for each study.

Study CDR/1000 (95 % CI)
Recall rate/100 (95 % CI)
SM/DBT DM/DBT DM SM/DBT DM/DBT DM
Paired studies
STORM-2 [28,29] 8.8 (7.0–10.8) 8.5 (6.7–10.5) 6.3 (4.8–8.1) 5.3 (4.9–5.8) 4.8 (4.4–5.2) 4.0 (3.6–4.4)
Martin (2018) [30] 5.4 (4.3–6.7) NR 4.1 (3.2–5.2) 3.0 (2.7–3.3) NR 3.1 (2.8–3.4)
OTST [20,[31], [32], [33]] 8.0 (6.9–9.2) 7.8 (6.8–9.0) 6.3 (5.3–7.3) 2.3 (2.1–2.5) 2.6 (2.4–2.8) NR
Summary estimate 7.3 (5.4–9.4) 8.0 (7.1–9.0) 5.5 (4.1–7.1) 3.4 (2.1–5.1) 3.1 (3.0–3.3) 3.4 (3.2–3.7)
Unpaired studies
VSP [21,34] 9.3 (7.9–10.9) NR 5.4 (4.3–6.7) 4.0 (3.7–4.3) NR 4.2 (3.9–4.6)
To-Be trial [19,36] 6.6 (5.3–8.1) NR 6.1 (4.9–7.0) 3.1 (2.8–3.4) NR 4.0 (3.7–4.3)
OVVV [22,37] 9.4 (8.4–10.4) NR 6.1 (5.5–6.8) 3.4 (3.2–3.6) NR 3.3 (3.2–3.4)
Aujero (2017) [38] 6.1 (4.9–7.4) 6.3 (5.5–7.3) 5.5 (4.7–6.4) 4.3 (3.9–4.6) 5.8 (5.6–6.1) 9.2 (8.8–9.5)
Freer (2017) [39] 5.9 (4.4–7.6) 6.9 (2.8–14.1) 5.9 (4.9–7.0) 5.8 (5.3–6.3) 7.0 (5.5–8.7) 8.7 (8.3–9.1)
Ambinder (2018) [40] 5.6 (4.4–6.9) 5.2 (3.8–7.1) NR 7.1 (6.7–7.5) 7.6 (7.1–8.2) NR
Houssami (2019) [41] 9.8 (7.2–12.9) NR 6.6 (4.6–9.2) 4.2 (3.7–4.8) NR 3.0 (2.6–3.5)
Zuckerman [14,42] 5.6 (5.0–6.2) 5.9 (5.4–6.4) NR 7.0 (6.8–7.2) 7.9 (7.7–8.1) NR
Cohen (2020) [43] 5.8 (4.9–6.9) 5.3 (5.0–5.6) 4.0 (3.9–4.2) 7.3 (6.9–7.6) 7.5 (7.4–7.7) 10.0 (9.9–10.1)
TSP [35] 8.7 (7.9–9.6) NR 5.5 (4.9–7.0) 2.6 (2.4–2.7) NR 3.2 (3.0–3.4)
Summary estimate 7.1 (6.0–8.3) 5.6 (5.1–6.1) 5.5 (4.6–6.5) 4.7 (3.5–6.1) 7.2 (6.5–7.9) 5.4 (3.2–8.2)
All studies 7.2 (6.3–8.1) 6.3 (5.5–7.2) 5.5 (4.8–6.4) 4.4 (3.4–5.6) 6.0 (4.7–7.5) 5.0 (3.0–7.4)

CDR cancer detection rate, SM synthesized mammography, DBT digital breast tomosynthesis, DM digital mammography, NR not reported, CI confidence interval.